Michigan residents who suffer heart attacks will get faster treatment with the most effective emergency heart procedures, under a new multi-hospital initiative being launched in Michigan this week.
A new study on liver retransplantation (re-LT) over a 15 year period at a clinic in Germany found that indications for the surgery had changed and there were fewer rejections, complications, and recurrence of disease during that time.
Active patient involvement during treatment of chronic heart failure, coupled with partnership with healthcare team members to provide care consistent with evidence-based guidelines, dramatically improves quality of care for chronic heart failure patients.
Ravgen publishes study in the Lancet describing a non-invasive test for prenatal diagnosis based on fetal DNA in maternal blood.
Iloprost is an inhaled drug currently used to treat individuals with pulmonary arterial hypertension (raised blood pressure in the blood vessels in the lungs that leads to shortness of breath, dizziness and fainting). However, the results of a new study in mice indicate that iloprost might provide an effective therapeutic for the treatment of individuals with allergic asthma.
Although treatment regimens involving the infusion of tumor-reactive T cells into patients with skin cancer (melanoma) have shown clinical benefit, there is plenty of room to improve the protocols to increase therapeutic benefit.
A trial of a new treatment to prevent HIV/AIDS transmission in women has been stopped prematurely because of a higher number of infections among those taking the microbicide cellulose sulfate compared with the placebo group, according to United Nations agencies involved.
A new study to find a non-invasive alternative to liver biopsy when diagnosing fibrosis found that a series of simple blood tests can accurately diagnose the condition.
An approved drug for fighting obesity is helping scientists at Wake Forest University School of Medicine uncover clues about how to stop the growth of cancerous tumors.
A research team led by Prof. Claude Perreault, Universit? de Montr?al, is announcing a major discovery in Genomics. This will generate a fundamental impact on the treatment of blood cancers (leukemias and lymphomes) by means of peripheral blood T-cell grafts.